Last --
Change Today 0.00 / 0.00%
Volume 0.0
4523 On Other Exchanges
Symbol
Exchange
4523 is not on other exchanges.
All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Hajime Shimizu

Chief Financial Officer, Representative Corporate Officer and Chief Financial Officer of Japan Subsidiaries - Chief Executive Officer's Special Mission, Eisai Co., Ltd.
AgeTotal Calculated CompensationThis person is connected to 4 board members in 2 different organizations across 3 different industries.

See Board Relationships
----

Background*

Mr. Hajime Shimizu serves as Chief Financial Officer at Eisai Co., Ltd. Mr. Shimizu serves as Deputy President and Chief Financial Officer of Japan Subsidiaries - Chief Executive Officer's special mission at Eisai Co. Ltd. Mr. Shimizu served as an Executive Vice President and President of New Markets & Asean at Eisai Co. Ltd. He served as Senior Vice President of Pharmaceuticals Business U S of Eisai Co. Ltd. Mr. Shimizu served as Chief Executive Officer of Eisai Corporation ...

Read Full Background

Corporate Headquarters*

4-6-10, Koishikawa
Tokyo, Tokyo 112-8088

Japan

Phone: 81 3 3817 3700
Fax: --

Board Members Memberships*

Chairman and Chief Executive Officer
2008-Present
Director

Education*

There is no Education data available.

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
4523:JP ¥4,242.00 JPY +28.00

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Michael W. Bonney B.A.Chief Executive Officer and Director
Cubist Pharmaceuticals Inc.
$750.0K
Carolyn J. Logan Chief Executive Officer, President and Director
Salix Pharmaceuticals Ltd.
$867.5K
Akira Kurokawa Chief Executive Officer, President and Director
Santen Pharmaceutical Co. Ltd.
--
Eduardo Javier Sanchiz Yrazu Chief Executive Officer, Member of Management Board, Chief Executive of Corporate Development & Finance, Executive Director and Member of Compliance Committee
Almirall, S.A.
--
Richard Martin Steeves BSc., Ph.D.Group Chief Executive Officer, Member of Senior Executive Board and Executive Director
Synergy Health plc
823.0K GBP
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact EISAI CO LTD, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.